The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 308.00
Ask: 308.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.162%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 306.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

22 Oct 2019 07:00

RNS Number : 5705Q
Synthomer PLC
22 October 2019
 

 

 

 

LEI Number: 213800EHT3TI1KPQQJ56

 

Synthomer plc ("the Company") - 2019 AGM voting outcome update statement

 

 

 

In its 2019 AGM results announcement, the Company reported that all resolutions were passed, although there was a significant minority vote against resolution 11 which related to the re-election of Neil Johnson, the Chairman of the Company, as a non-executive director. Total votes received in favour of this resolution were 64.72%.

 

Following the AGM results, the Company has actively sought to engage in dialogue with a number of significant shareholders who voted against Neil's re-election and with a leading proxy voting advisory body. The dialogue was initiated in order to better understand the reasons behind the dissenting votes, which were based on:

 

·; Concerns over Neil's availability to devote sufficient time to carry out his responsibilities as Chairman of the Company ("over boarding"); and

 

·; The absence of a commitment and plan by the Synthomer Board ("the Board") to implement the Hampton-Alexander Review Recommendation of 33% representation of women on the Board by the end of 2020) ("the Recommendation").

 

 

The Board has carefully considered the over boarding' concerns which are understood to arise due to Neil's role as chair of two other public company boards - QinetiQ Group plc (QinetiQ) and Electra Private Equity plc (Electra). Whilst the Board acknowledges that Neil's role as chairman of the QinetiQ board is a significant commitment which should be counted as such this is not however considered to be the case with his chairmanship of Electra. As Electra has publicly stated, it is conducting a managed wind-down of its final few investments and reducing overheads prior to closing the fund which has currently resulted in it having only two employees and requiring minimal input from Neil. Accordingly, the Board strongly believes that Neil is an effective Chairman with sufficient capacity to meet his commitments, and has no concerns over his availability to deal with Company matters.

 

The Board adopted its current policy on diversity in 2014 and has not recommended the setting of quotas for female or other representation. The Board has appointed women to fill the most recent two vacancies that have arisen for independent non-executive directors resulting in female representation of 22.2% on the Board since September 2018. In order to address both the Recommendation and the need for the refreshment of independent non-executive directors over the next 18 months in accordance with the provisions of the UK Corporate Governance Code ("the Code") the Board has decided to commit to the appointment of an additional female independent non-executive director by the end of 2020. Whilst this will increase the size of the Board in the short term to 10 it is expected that the Board will reduce to 9 during the first half of 2021. It should be noted that the Board has two long standing male non independent non-executive directors who are not subject to the tenure requirements of the Code and who each continue to provide a highly valued contribution.

 

The Board will continue to engage with shareholders on these points as required and will set out further details of any such dialogue and relevant justification for the re-election for all members of the Board in the 2020 annual report and accounts and associated documentation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMBGBDGBSDBGCB
Date   Source Headline
5th Aug 20221:20 pmRNSHolding(s) in Company
5th Aug 202211:27 amRNSDirector/PDMR Shareholding
4th Aug 20222:57 pmRNSDirector/PDMR Shareholding
4th Aug 20222:35 pmRNSDirector/PDMR Shareholding
3rd Aug 202212:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSResults for the six months ended 30 June 2022
15th Jul 20222:32 pmRNSHolding(s) in Company
8th Jul 202210:23 amRNSHolding(s) in Company
1st Jul 20227:00 amRNSChief Financial Officer
30th Jun 20225:04 pmRNSHolding(s) in Company
21st Jun 20227:00 amRNSAppointment of Non-Executive Director
17th May 202212:55 pmRNSHolding(s) in Company
5th May 202212:39 pmRNSHolding(s) in Company
4th May 20224:46 pmRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSAppointment of Joint Corporate Brokers
28th Apr 202212:24 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 2022 trading update
26th Apr 20229:33 amRNSHolding(s) in Company
20th Apr 20224:13 pmRNSHolding(s) in Company
5th Apr 20224:18 pmRNSDirector/PDMR Shareholding
1st Apr 20221:34 pmRNSCompletion of adhesives acquisition
29th Mar 20223:17 pmRNSHolding(s) in Company
29th Mar 20223:14 pmRNSDirector/PDMR Shareholding
25th Mar 20222:03 pmRNSAnnual Financial Report
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:48 pmRNSDirector/PDMR Shareholding
14th Mar 20229:35 amRNSHolding(s) in Company
9th Mar 202212:52 pmRNSDirector/PDMR Shareholding
8th Mar 20223:22 pmRNSDirector/PDMR Shareholding
8th Mar 20223:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSPreliminary Results for the year ended 31 Dec 2021
14th Feb 20227:00 amRNSPre-close trading update
10th Feb 20223:10 pmRNSNOTIFICATION OF MAJOR HOLDINGS
22nd Dec 20215:10 pmRNSDirector/PDMR Shareholding
21st Dec 20213:09 pmRNSDirector/PDMR Shareholding
20th Dec 20213:40 pmRNSDirector/PDMR Shareholding
17th Dec 202112:29 pmRNSResults of General Meeting
15th Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20214:57 pmRNSPUBLICATION OF CIRCULAR
26th Nov 20217:00 amRNSAppointment of Chief Financial Officer
22nd Nov 202110:36 amRNSDirector Declaration
11th Nov 20212:24 pmRNSDirector/PDMR Shareholding
4th Nov 20212:11 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSNew Chief Executive
28th Oct 20213:17 pmRNSResult of Placing
28th Oct 20217:00 amRNSAcquisition
28th Oct 20217:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
30th Sep 20213:08 pmRNSDirectorate Change
10th Sep 20218:23 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.